Bank Pictet & Cie (Asia)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$363K Hold
669
0.02% 70
2024
Q1
$347K Sell
669
-2,383
-78% -$1.19M 0.03% 80
2023
Q4
$1.44M Buy
+3,052
New +$1.41M 0.36% 60

Other funds holding ELV

Bank Pictet & Cie (Asia)'s ELV Position: Q2 2024 in Review

Bank Pictet & Cie (Asia) held its Elevance Health (ELV) position steady in Q2 2024 at 669 shares worth $363K. The position accounts for 0.02% of the portfolio, ranked #70.

Bank Pictet & Cie (Asia) first reported a position in ELV in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.44M in Q4 2023. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Bank Pictet & Cie (Asia) held 669 shares of Elevance Health worth $363K as of Q2 2024.
  • Bank Pictet & Cie (Asia) left its Elevance Health share count unchanged in Q2 2024.
  • Elevance Health made up 0.02% of Bank Pictet & Cie (Asia)'s portfolio in Q2 2024, its #70 holding.
  • Bank Pictet & Cie (Asia) first reported a position in Elevance Health in Q4 2023 and has held it in 3 quarters since.
  • Bank Pictet & Cie (Asia)'s Elevance Health position peaked at $1.44M in Q4 2023.
  • 1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2024, filed 16 Jul 2024.